Clin2
NCT07464184Possibly a fitNot yet recruiting

Monitoring breathing and heart rate during pulmonary hypertension treatment

Precapillary Pulmonary HypertensionPulmonary Arterial HypertensionSleep-disordered BreathingNocturnal HypoxemiaAutonomic Nervous System DysfunctionHeart Rate Variability (HRV)Cardiovascular Risk

Part of Brain & nervous system, Heart & circulation, Lungs & breathing clinical trials.

This study looks at how your heart and lungs respond to starting a blood vessel–widening medication (a vasodilator) for pulmonary hypertension. It will closely monitor your breathing and heart rhythm to help doctors understand and improve treatment.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older, and you have been diagnosed with a specific type of pulmonary hypertension (high blood pressure in the lungs) confirmed by a catheter test.
  • You have been prescribed a vasodilator, a medicine that opens up blood vessels to lower pressure, for your pulmonary hypertension.
  • You cannot be using a breathing machine (non-invasive ventilation) at home.
  • You do not have certain other serious conditions that would make the trial unsafe, such as Eisenmenger syndrome, systemic scleroderma, or a recent heart attack, and you do not have a pacemaker.
  • If you are a woman who can become pregnant, you must be using reliable birth control and have a negative pregnancy test before joining.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07366879Recruiting
Exercise program for newly diagnosed pulmonary hypertension

This study tests whether a home-based exercise program, added to your regular medications, can help people who are newly diagnosed with pulmonary arterial hypertension feel better and improve their daily function.

Glasgow
NCT07143448Recruiting· Phase 1/Phase 2
Study of HS235 for pulmonary arterial hypertension in adults

This trial tests an experimental drug called HS235 for people with pulmonary arterial hypertension (PAH), a condition of high blood pressure in the lungs. It aims to see if the drug can help improve symptoms and exercise ability.

Tampa, Florida
NCT05368467Recruiting
Registry study for pulmonary hypertension patients

This is a long-term study that enrolls people who have been diagnosed with pulmonary hypertension (high blood pressure in the lung arteries). It collects medical information over time to better understand the condition and what to expect.

Guangzhou, Guangdong
NCT05958901Recruiting
Study of pulmonary hypertension in everyday clinical care

This observational study is looking at people diagnosed with pulmonary hypertension to better understand how it behaves over time. You may help researchers by allowing repeated check-ins for years and sharing symptom and test information.

Guangzhou, Guangdong
NCT04078243Recruiting
Trial setup and testing in adults with pulmonary hypertension

This study tests new “trial tools” and designs for running early research in people with pulmonary hypertension. If you qualify, you may be asked to do extra trial-related procedures to help researchers test the process safely and smoothly.

Sheffield, South Yorkshire
NCT06703801Enrolling by invitation
Tracking pulmonary hypertension and quality of life

This study is tracking people with pulmonary hypertension (high blood pressure in the lungs) over time to see how their condition and quality of life change. By joining, you help doctors better understand the disease and improve care for others like you.

Hong Kong

Hear when a new Precapillary Pulmonary Hypertension trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.